This federal contract award is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 ml, awarded to the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $24,002.84 and an ultimate completion date of December 4, 2024. It was awarded on December 3, 2024 as a delivery order under a Firm Fixed Price contract type.
The contracting agency is the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support to the military services, combat support agencies, and other Department of Defense and federal agencies. This contract is part of DLA Troop Support Medical's extensive Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies.
Generated 3/4/25, 11:24 AM